Expanding Applications and Evolution of Technology to Drive the Metabolomics Market

Expanding applications for the technology, as well as increasing R&D activity in the lifesciences industry to utilize Metabolomics as a viable tool in drug discovery are poised to drive the global Metabolomics market to exceed US$2.8 billion by 2024.

Metabolomics is a dynamic concept and a newly emerging field of omic sciences. Metabolomics is the study of chemical processes involving metabolites and provides information on the chemical fingerprints of various cellular processes. Metabolites are small molecules contained in tissues, blood and urine. Metabolomics of biological specimens derived from urine, blood and cells are relatively cheap and less invasive. The concept of Metabolomics emerged as a research tool that complements all other "omics" technologies at the metabolite level. Metabolomics or Metabolite Profiling provides a more holistic view of the phenotype of organelles, organs, tissues, cells and whole organisms, when compared to DNA, RNA, or protein profile. With proteomic and genomic analysis proving inadequate in offering comprehensive information, researchers are shifting focus onto metabolic profiling to gain detailed insights into the cell’s physiology. Metabolomics has evolved rapidly in recent years in- sync with advances in separation and analysis technologies related to mass spectroscopy (MS) and nuclear magnetic resonance (NMR) based detection techniques.

Metabolomics offers potential for high growth, primarily due to the effervescent technological developments in the fields of molecular biology and biochemistry. The technology is in an evolutionary stage in the field of analytical biochemistry and is likely to witness higher growth in the coming years driven by increased adoption in drug development processes and for using the research data in drug filing as well as for the optimization of lifecycle management of commercialized drugs. Technological breakthroughs in analytical technologies and advances in data processing and analysis software are expected to further boost growth prospects. Growth in the Metabolomics market would be driven by the increasing volume of clinical trials, growing awareness about nutritional products, rise in toxicological studies, growth of Metabolomics data analysis solutions and software, and the increasing use of Metabolomics as a diagnostic tool for biomarker screening of various diseases. As Metabolomics involves high degree of analysis, significant emphasis has been placed on the maintenance of databases. These databases have in turn fostered growth of management systems such as Metabolomics [LIMS] Laboratory Information Management Systems, which assist by enhancing efficiency, security, data integrity and communication.

A major application area for Metabolomics is life sciences, with growth continuing to be driven by technology advances and increased use of computers and information technology. The use of Metabolomics to uncover novel disease biomarkers is witnessing rapid growth. Competence to develop novel drugs together with disease biomarkers is a striking strategy to enhance efficacy and cut down drug discovery attrition. Another area where Metabolomics is beginning to gain significance is food sciences, wherein Metabolomic profiling is being utilized in the identification of the quality, nutritional value, and taste of the food products. Preclinical and clinical research and drug discovery constitute other key application areas for Metabolomics. Lucrative application areas that are expected to fuel future market growth include toxicology screening, biofuels R&D, food & beverage analysis, plant genomics, nutrigenomics, and systems biology. Metabolomics approach has an important role to play in toxicology testing to identify toxic effects of drug early on in the drug discovery process. Metabolomics also holds potential for the agriculture sector wherein Metabolomics will help improve the productivity of agricultural crops. Other factors that would continue to drive growth into the future include the growing demand for customized medicine based on individual metabolite profile; increased funding for Metabolomics research by both government and research firms, and aging population and subsequent rise in age-related chronic illnesses.

As stated by the new market research report on Metabolomics, the United States represents the largest market followed by Europe, driven by the presence of a sophisticated healthcare infrastructure conducive to pharmaceutical R&D. Asia-Pacific ranks as the fastest growing market with a CAGR of 17.8% over the analysis period. Aging population, increase in age-related chronic illnesses, improving healthcare infrastructure, growing number of pharmaceutical and biotech companies, rising demand for improved pharmaceutical products, and increased investments in life science research are factors driving growth in the region. By Application/Technology, Bioanalytical Instruments and Equipment represent the largest segment, while Bioinformatics Tools in Metabolomic Research are expected to offer the best growth opportunities over the analysis period.

Key players in the market include AB SCIEX, Agilent Technologies Inc., Biocrates Life Sciences AG, Metanomics GmbH, Bio-Rad Laboratories Inc., Bruker Corporation, Chenomx Inc., Human Metabolome Technologies Inc., LECO Corporation, Metabolon Inc., Shimadzu Corporation, SiDMAP LLC, Thermo Fisher Scientific Inc. and Waters Corporation, among others.

The research report titled "Metabolomics: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, innovations and launches, and strategic industry activities various players. The report provides market estimates and projections in US$ million for Metabolomics for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), Asia-Pacific, Latin America, and Rest of World. Applications/Technologies analyzed for the global market include Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

For cutting edge analyst reviews on top industries

Follow us on Twitter; Connect with us on LinkedIn; Follow us on Medium